The Christie NHS Foundation Trust and The King Hussein Cancer Centre (KHCC) in Jordan have signed a memorandum of understanding to support and train a team there in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). The KHCC is a not-for-profit specialist cancer centre funded by charity.
As part of this, Mr. Omer Aziz and Professor Sarah O’Dwyer travelled to Jordan in December 2018 and performed their first 2 CRS/HIPEC cases with the KHCC team. They also delivered a grand round presentation, were invited to see the KHCC patients and to meet with their radiologists and oncologists.
Through this initiative, The Christie colorectal and peritoneal oncology centre (CPOC) aims to help establish this treatment for patients with advanced cancers in the Jordan and the Middle East.
The KHCC team see The Christie CPOC team as an important partner in establishing CRS/HIPEC in Jordan. The success of this initiative also demonstrates the reputation of The Christie CPOC as a leading expert in CRS/HIPEC.
After Mr. Omer Aziz and Professor Sarah O’Dwyer returned to The Christie, the KHCC team sent an update from the patients they operated on. Pictured below are the KHCC team with the patients fully recovered from surgery.